| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 27.62▼ | 27.62▼ | 27.61▼ | 27.85▼ | 27.77▼ |
| MA10 | 27.62▼ | 27.62▼ | 27.68▼ | 27.87▼ | 27.81▼ |
| MA20 | 27.61▼ | 27.69▼ | 27.78▼ | 27.83▼ | 27.70▼ |
| MA50 | 27.66▼ | 27.83▼ | 27.87▼ | 27.84▼ | 27.46▲ |
| MA100 | 27.74▼ | 27.87▼ | 27.86▼ | 27.71▼ | 27.32▲ |
| MA200 | 27.85▼ | 27.83▼ | 27.83▼ | 27.48▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.004▲ | 0.002▲ | -0.020▼ | -0.016▼ | -0.012▼ |
| RSI | 33.030▼ | 22.375▼ | 20.648▼ | 34.726▼ | 49.616▼ |
| STOCH | 62.500 | 30.132 | 5.255▼ | 60.755 | 44.163 |
| WILL %R | -100.000▼ | -95.238▼ | -95.833▼ | -88.372▼ | -74.194 |
| CCI | -112.381▼ | -49.506 | -74.480 | -270.871▼ | -36.279 |
|
Friday, October 31, 2025 05:05 AM
Amid some scrutiny over its latest-generation G7 CGM, Dexcom officials addressed claims on the company's latest earnings call.
|
|
Thursday, October 30, 2025 08:12 PM
DexCom Inc (DXCM) reports a robust 22% increase in worldwide revenue, driven by expanded CGM access and strategic market advancements.
|
|
Thursday, October 30, 2025 01:30 PM
Dexcom (Nasdaq:DXCM) shares took a hit after hours today on third-quarter results that came in ahead of the consensus forecast.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 31/10/25 | 27.64 | 27.67 | 27.56 | 27.61 | 801,116 |
| 30/10/25 | 27.78 | 27.84 | 27.777 | 27.80 | 885,900 |
| 29/10/25 | 27.96 | 27.98 | 27.86 | 27.89 | 949,319 |
| 28/10/25 | 27.97 | 27.99 | 27.9501 | 27.99 | 823,181 |
| 27/10/25 | 27.94 | 27.99 | 27.93 | 27.98 | 807,040 |
| 24/10/25 | 27.92 | 27.93 | 27.885 | 27.93 | 586,684 |
| 23/10/25 | 27.86 | 27.89 | 27.85 | 27.86 | 863,286 |
| 22/10/25 | 27.88 | 27.89 | 27.84 | 27.88 | 634,941 |
| 21/10/25 | 27.90 | 27.92 | 27.86 | 27.89 | 868,475 |
| 20/10/25 | 27.86 | 27.89 | 27.85 | 27.89 | 655,622 |
|
|
||||
|
|
||||
|
|